These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 16965207

  • 1. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS, Barnhill LJ, Khalid AS, Davis JM.
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [Abstract] [Full Text] [Related]

  • 2. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS, Barnhill LJ, Khalid AS, Davis JM.
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS, Barnhill LJ, Davis JM.
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [Abstract] [Full Text] [Related]

  • 4. Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature.
    Hässler F, Reis O.
    Dev Disabil Res Rev; 2010 Oct; 16(3):265-72. PubMed ID: 20981765
    [Abstract] [Full Text] [Related]

  • 5. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS, Barnhill LJ, Shetty M, Davis JM.
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [Abstract] [Full Text] [Related]

  • 6. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S, Unwin G, Deb T.
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [Abstract] [Full Text] [Related]

  • 7. Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study.
    Janowsky DS, Kraus JE, Barnhill J, Elamir B, Davis JM.
    J Clin Psychopharmacol; 2003 Oct; 23(5):500-4. PubMed ID: 14520128
    [Abstract] [Full Text] [Related]

  • 8. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V, Fehér L.
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [Abstract] [Full Text] [Related]

  • 9. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS, Shetty M, Barnhill J, Elamir B, Davis JM.
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):37-48. PubMed ID: 15482629
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F, Glaser T, Pap AF, Beneke M, Diefenbacher A, Reis O, Zuclopenthixol Disruptive Behavior Study Group.
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [Abstract] [Full Text] [Related]

  • 11. Effects of zuclopenthixol on aggressive disruptive behavior in adults with mental retardation--a 2-year follow-up on a withdrawal study.
    Hässler F, Glaser T, Reis O.
    Pharmacopsychiatry; 2011 Nov; 44(7):339-43. PubMed ID: 21993867
    [Abstract] [Full Text] [Related]

  • 12. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ, Koedoot PJ, Heerdink ER, Leufkens HG, Nolen WA.
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [Abstract] [Full Text] [Related]

  • 13. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
    Linaker OM.
    Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD007726. PubMed ID: 23543555
    [Abstract] [Full Text] [Related]

  • 15. A critical appraisal of recent drug research in mental retardation: the Coldwater studies.
    Aman MG, Singh NN.
    J Ment Defic Res; 1986 Sep 28; 30 ( Pt 3)():203-16. PubMed ID: 2878082
    [Abstract] [Full Text] [Related]

  • 16. Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study.
    Bridges-Parlet S, Knopman D, Steffes S.
    J Geriatr Psychiatry Neurol; 1997 Jul 28; 10(3):119-26. PubMed ID: 9322135
    [Abstract] [Full Text] [Related]

  • 17. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
    Martin JE, Agran M.
    Appl Res Ment Retard; 1985 Jul 28; 6(1):33-49. PubMed ID: 2859836
    [Abstract] [Full Text] [Related]

  • 18. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.
    Branford D.
    J Intellect Disabil Res; 1996 Aug 28; 40 ( Pt 4)():322-9. PubMed ID: 8884587
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and drug use in mentally retarded, emotionally disturbed adults.
    Matson JL, Kazdin AE, Senatore V.
    Appl Res Ment Retard; 1984 Aug 28; 5(4):513-9. PubMed ID: 6151823
    [Abstract] [Full Text] [Related]

  • 20. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone.
    Colella RF, Ratey JJ, Glaser AI.
    Int J Psychiatry Med; 1992 Aug 28; 22(4):351-6. PubMed ID: 1293064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.